MERCK NewsLatest News On MERCK China Emerges as a Hotbed for Drug Innovation, Attracting Big Pharma Investments2/13/2025 7:05 AM Merck Stock Plummets Despite Strong Q4 Earnings Due to Disappointing 2025 Guidance2/4/2025 3:20 PM Merck's 2025 Revenue Guidance Falls Short as Gardasil Shipments to China Pause2/4/2025 6:24 AM Kennedy to Divest From Vaccine Lawsuit if Confirmed as HHS Secretary1/31/2025 6:29 PM Cramer: Invest in Pharmaceutical Stocks for Long-Term Growth1/14/2025 7:47 PM Cramer Sees Long-Term Potential in Healthcare Stocks, Highlights Eli Lilly and Merck as Winners1/14/2025 6:31 PM Merck Buys Experimental Weight Loss Pill from Hansoh for Up to $2 Billion12/18/2024 7:55 AM Merck Acquires Experimental Weight Loss Pill Rights for Up to $2 Billion12/18/2024 7:37 AM Merck Acquires Rights to Experimental Weight-Loss Pill for Up to $2 Billion12/18/2024 7:25 AM Merck Snags Rights to Experimental Weight Loss Pill in $2 Billion Deal12/18/2024 7:21 AM Merck Snags Rights to Experimental Weight-Loss Pill for Up to $2 Billion12/18/2024 7:05 AM As Drug Maker Stocks Fall, Pressure Builds On PhRMA To Derail RFK Jr.11/15/2024 9:16 PM InnovationRx: Health Officials Brace For West Nile Virus6/19/2024 2:20 PM InnovationRx: Tarsus Pharmaceuticals Takes Aim At Disease-Causing Bugs6/12/2024 4:38 PM Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference6/5/2024 6:01 PM What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck6/4/2024 9:19 AM Data Tools Are Hammers. Tableau Want To Give You A Nail Gun5/1/2024 11:26 AM U.K. Tests World-First Personalized Skin Cancer Vaccine4/26/2024 10:10 AM
